Breaking News

You are here » Indian-Commodity  :  Top News  :  Zydus Cadila gets USFDA's final nod for Acetazolamide ER Capsules

17-Jan2019

Zydus Cadila gets USFDA's final nod for Acetazolamide ER Capsules

Zydus Cadila has received the final approval from the US Food and Drug Administration (USFDA) to market Acetazolamide ER Capsules (US RLD -Diamox). It will be manufactured at the group's formulations manufacturing facility at Moraiya, Ahmedabad.

Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used to treat certain types of glaucoma (caused by increased ocular pressure) and to treat or prevent altitude sickness (acute mountain sickness).

The group now has 246 approvals and has so far filed over 330 ANDAs since the commencement of the filing process in FY 2003-04.

Zydus Cadila is an innovative, global pharmaceutical company that discovers, develops, manufactures and markets a broad range of healthcare therapies.


Related News

View all news

Gold futures edge higher on Monday

Gold futures edged higher on Monday, despite a firm dollar followed by reports of better than expected economic growth of US. However, investments were almost muted after the long Easter weekend.Gold futures......

Physical rubber prices ruled steady on Saturday

Physical Rubber prices ruled steady on Saturday. Spot prices for RSS-4 and RSS-5 variety closed unchanged at Rs 128/ kg and Rs 125/ kg respectively.In the futures market, May delivery gained to Rs 129.89......

Jeera futures trade lower on easing demand

Jeera futures traded lower on NCDEX on account of easing demand from retailers and industrial buyers at the spot market. Further, ample stocks position following higher supplies from the producing belts......

Top News

View all news

Bank of Baroda's board to consider issuance of equity shares of Rs 5,042 crore to Govt

Bank of Baroda's board is going to consider issuance of equity shares of Rs 5,042 crore to Government of India on a Preferential Basis. The meeting of the Board of Directors of the Bank is scheduled to......

Gujarat Petrosynthese to invest surplus funds in mutual funds, bonds, securities, shares

Gujarat Petrosynthese has received an approval to invest surplus funds in mutual funds, bonds, securities, shares, inter corporate deposits etc. to optimize its returns. The Board of Directors of the Company......

Reliance's Retail Unit delivers record-breaking performance in revenue, profits during FY19

Reliance Industries' Retail Unit--Reliance Retail has delivered a record-breaking performance in revenue and profits growth for the year 2018-19. Segment Revenue for FY19 grew by 88.7% Y-o-Y to Rs 130,566......